financetom
Business
financetom
/
Business
/
Update: Mandalay Resources Gains 5% as Q1 Production Falls
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Mandalay Resources Gains 5% as Q1 Production Falls
Apr 11, 2025 9:27 AM

12:00 PM EDT, 04/11/2025 (MT Newswires) -- (Updates shares.)

Mandalay Resources ( MNDJF ) said Friday its gold equivalent production fell in the first quarter.

The company produced 22,342 gold equivalent ounces in the quarter, dropping from 24,936 gold equivalent ounces.

Mandalay's first-quarter output comprised 20,376 ounces of gold and 161 tonnes of antimony.

Despite the decline, Mandalay said it remains on track to meet its annual production guidance of 85,000-95,000 gold equivalent ounces.

"2025 marks a pivotal year for both sites, with mine development and capital investment projects underway," said Frazer Bourchier, Mandalay's president and CEO. "We have allocated $43-$48 million in sustaining capital to enhance mining flexibility and support long-term growth."

Mandalay shares were last seen up $0.24 to $5.15 on the Toronto Stock Exchange.

Price: 5.15, Change: +0.24, Percent Change: +4.89

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Vaxart Gets Increased Funding for COVID-19 Pill Vaccine Study
Dec 27, 2024
11:20 AM EST, 12/27/2024 (MT Newswires) -- Vaxart ( VXRT ) said an agreement with Advanced Technology International on a COVID-19 vaccine candidate study was amended with an increase of $4.6 million in the total estimated ceiling for funding to $460.7 million. The project agreement in June covered funding for a comparative study to evaluate the company's oral pill XBB...
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Novartis must face claims it paid kickbacks to promote MS drug, US appeals court rules
Dec 27, 2024
NEW YORK (Reuters) - A U.S. appeals court on Friday revived a whistleblower lawsuit accusing the Swiss drugmaker Novartis of paying illegal kickbacks to doctors to induce them to promote its blockbuster multiple sclerosis drug Gilenya. In a 3-0 decision, the 2nd U.S. Circuit Court of Appeals in Manhattan said the whistleblower Steven Camburn can try to prove that Novartis...
What's Going On With Rail Vision Stock On Friday?
What's Going On With Rail Vision Stock On Friday?
Dec 27, 2024
Rail Vision Ltd. ( RVSN ) saw its shares rise on Friday after announcing a major achievement in railway safety. The company revealed it had received certification approval for the installation of its MainLine Systems on Israel Railways’ passenger locomotives. This milestone triggers a $300,000 milestone payment and positions Rail Vision ( RVSN ) for potential future volume procurement from...
Microsoft-Backed OpenAI Considers Transitioning to Conventional For-Profit Company
Microsoft-Backed OpenAI Considers Transitioning to Conventional For-Profit Company
Dec 27, 2024
11:16 AM EST, 12/27/2024 (MT Newswires) -- Microsoft ( MSFT )-backed (MSFT) OpenAI is looking at reorganizing itself to become a Delaware public benefit corporation in order to raise conventional capital while maintaining a nonprofit arm, according to an OpenAI blogpost Thursday. OpenAI currently operates as both a nonprofit and for-profit entity, supported by investments from Microsoft ( MSFT )...
Copyright 2023-2026 - www.financetom.com All Rights Reserved